Slosarek, Tamara
Ibing, Susanne
Schormair, Barbara
Heyne, Henrike O.
Böttinger, Erwin P.
Andlauer, Till F. M.
Schurmann, Claudia
Funding for this research was provided by:
Horizon 2020 Framework Programme (826117, 826117)
Hasso-Plattner-Institut für Digital Engineering gGmbH
Article History
Received: 29 November 2022
Accepted: 27 March 2023
First Online: 5 April 2023
Declarations
:
: The described genomics course with PGT opportunity was approved by the ethics board of the University of Potsdam with the application number 17/2021. All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all study participants.
: Not applicable
: Drs. Andlauer and Schurmann are salaried employees of Boehringer Ingelheim Pharma and Bayer AG, respectively. All other authors declare that they have no competing interests.